Dr. Nolan Williams is an Associate Professor of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Brain Stimulation Lab. The long-term goals of his research program are to develop innovative technologies and therapeutics capable of modulating the neural circuitry disrupted in mood disorders, OCD, and other neuropsychiatric conditions. His team has been developing neuroimaging-based approaches to precisely target therapeutic delivery and predict treatment responses to therapeutic neuromodulation and psychedelics. Dr. Williams earned his M.D.

The Cong lab develops novel technologies at the intersection of genome engineering, single-cell analysis, and computational genomics. They focus on immune-related disease to employ these tools for understanding cancer immunology, neuro-immunology, and mechanistic insights that may lead to transformative diagnostics or therapeutics with tailored genetic/epigenetic approaches.

Dr. Gomez-Ospina is a physician scientist and medical geneticist with a strong interest in the diagnosis and management of genetic diseases.

Dr. Duncan's group studies genetic and environmental effects on mental health: much of their work is computational and relies upon genetic data collected from millions of individuals.

Dr. Itakura's research focuses on developing methods for integrative analysis of multi-scale cancer data to improve patient outcomes. She uses machine learning and radiogenomic approaches to accelerate discoveries in cancer diagnostics and therapeutics.

The Frock lab uses genome-wide chromosomal translocation sequencing technologies to understand DNA double-strand break (DSB) repair. They apply these technologies to develop cancer diagnostics/treatments and to improve gene editing approaches.

The Mercola laboratory is focused on developing new therapies for cardiovascular disease: their research combines in vitro disease models using cardiovascular cells generated from induced pluripotent stem cells with high throughput screening to define disease mechanisms, identify drug targets and develop drug leads.

Dr. Shen's research interests include gastrointestinal and pancreatobiliary pathology, with major emphasis on GI and pancreatic neoplasia, inflammatory bowel disease, and the application of emerging technologies to pathology.

The Kaltschmidt lab’s goal is to understand the molecular basis of neuronal circuit formation. They are particularly interested in circuits that underlie locomotion, sexual function and gut motility.

The ultimate goal of Dr. Yang Hu's laboratory is to develop efficient therapeutic strategies to achieve CNS neural repair, through promoting neuroprotection, axon regeneration and functional recovery.

Specifically, they are using state-of-the-art tools and creating novel tools to study retinal ganglion cell (RGC) and optic nerve in various optic neuropathies including traumatic, glaucomatous and inflammatory optic nerve injuries, to fully understand the molecular mechanisms of CNS neurodegeneration and axon regeneration failure.